Letter to mendeni et al

Clinical Infectious Diseases

Volumn 53, Issue 6, 2011, Pages 613-614

  Van Der Pas, Vincent R ^a   Hoepelman, Andy I M ^a   Arends, Joop E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; DIDANOSINE; EFAVIRENZ; NEVIRAPINE; STAVUDINE; ZALCITABINE;

ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX; FIB 4; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; LABORATORY TEST; LETTER; LIVER FIBROSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; SCREENING TEST; THROMBOCYTE;

BIOLOGICAL MARKERS; FEMALE; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS; MALE;

EID: 80052210073     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir479     Document Type: Letter

References (9)

1. Mendeni M, Focá E, Gotti D, et al. Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection. Clin Infect Dis 2011; 52:1164-73.
2. Mauss S, Henke J, Berger F, Hegener P, Schmutz G. Screening for liver fibrosis in HIV-mono-infected patients with increased ALT comparing FibroScan with FIB-4. J Int AIDS Soc 2008; 11(Suppl 1):135.
3. HassonH, Gallotta G, Porrino L, et al. Transient elastometry and other non invasive tools to assess liver fibrosis in hivmonoinfected persons on antiretroviral drugs [abstract 273]. In: Programs and abstracts of the The Liver Meeting 2010 (Boston). Alexandria, VA: American Association for the Study of Liver Diseases. 2010; 459A.
4. Sanchez-Conde M, Montes-Ramirez ML, Miralles P, et al. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers. J Viral Hepat 2010; 17:280-6.
5. Cacoub P, Carrat F, Bedossa P, et al. Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study-ANRS HC02. J Hepatol 2008; 48:765-73.
6. Kirk GD, Astemborski J, Mehta SH, et al. Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection. Clin Infect Dis 2009; 48:963-72.
7. Vergara S, Macias J, Rivero A, et al. The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection. Clin Infect Dis 2007; 45: 969-74. (Pubitemid 47580344)
8. Nú ñez Marina. Hepatotoxicity of antiretrovirals: incidence, mechanisms and management. J Hepatol 2006; 44(Suppl 1):S132-9.
9. Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD. Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections. Hepatology 2002; 35:182-9. (Pubitemid 34032559)